Mangrove Partners’s Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 LHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-380,612
Closed -$3.79M 440
2022
Q3
$3.79M Buy
380,612
+310,672
+444% +$21.6K 0.22% 182
2022
Q2
$690K Buy
+69,940
New +$14.1K 0.03% 413

Other funds holding LHC.WS

Mangrove Partners's LHC.WS Position: Q4 2022 in Review

Mangrove Partners sold out of Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (LHC.WS) in Q4 2022, closing a stake of 380,612 shares — an estimated $3.79M sold.

Mangrove Partners first reported a position in LHC.WS in Q2 2022 and held it in 2 quarters. The position peaked at $3.79M in Q3 2022. 7 funds tracked by Wall St. Rank hold LHC.WS as of Q4 2022.

  • Mangrove Partners reported no remaining Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Mangrove Partners sold 380,612 Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $3.79M.
  • Mangrove Partners first reported a position in Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2022 and held it in 2 quarters.
  • Mangrove Partners's Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $3.79M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Mangrove Partners's 13F filing for Q4 2022, filed 14 Feb 2023.